TEVA

Read more
Kaare Schultz's photo - President & CEO of TEVA

President & CEO

Kaare Schultz

CEO Approval Rating

68/100

Founded:

1901

Status:

PublicIndependent CompanyNYSETEVA

TEVA TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Abbott is the top competitor of TEVA. Abbott is a Public company that was founded in Abbott Park, Illinois in 1888. Abbott operates in the Health Care Equipment industry. Abbott has 66,465 more employees vs. TEVA.

Merck is seen as one of TEVA's biggest rivals. Merck was founded in Kenilworth, New Jersey} in 1891. Like TEVA, Merck also operates in the Pharmaceuticals sector. Compared to TEVA, Merck generates $31.7B more revenue.

Mylan is perceived as one of TEVA's biggest rivals. Mylan was founded in 1961, and is headquartered in Canonsburg, Pennsylvania. Like TEVA, Mylan also competes in the Pharmaceuticals space. Mylan generates $4.8B less revenue vs. TEVA.

TEVA Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$16.3B

TEVA's revenue is the ranked 16th among it's top 10 competitors. The top 10 competitors average 27.7B. Over the last four quarters, TEVA's revenue has grown by 2.9%. Specifically, in Q1 2021's revenue was $4B; in Q4 2020, it was $4.5B; in Q3 2020, it was $4B; in Q2 2020, TEVA's revenue was $3.9B.

TEVA Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION

-

Actavis Generics, Allergan

Aug 2016

Source »
$40.5B
-
Anda, Inc.

Aug 2016

Source »
$500M
Anda distributes generic, brand and specialty pharmaceutical products, vaccines, injectables and over-the-counter medicines to independent pharmacies.
Representaciones e Investigaciones Médicas, S.A. de C.V.

Oct 2015

Source »
$2.3B
Rimsa Laboratories designs, develops, manufactures and markets generic drug products for the treatment of musculoskeletal.
Gecko Health Innovations, Inc.

Aug 2015

Source »
undisclosed
CareTRx is a novel cloud-based solution designed to simplify chronic respiratory disease management through remote monitoring and adherence tools.
Immuneering Corp

Aug 2015

Source »
undisclosed
Immuneering is a cloud-based bioinformatics platform that provides drug analytical solutions for the pharmaceutical and biotechnology companies.

TEVA Funding History

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt
Nov 2019
$2.1B
-
Debt
Apr 2019
$2.3B

Bank of America

Debt
Mar 2018
$4.5B
-
IPO
May 2012
--
-
Debt
Dec 2008
$1.8B

TEVA Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

CTI BioPharma focuses on the acquisition, development and commercialization of targeted therapies to treat blood-related cancers.
$10M
Dec 13, 2015
Unattributed
Mar 20, 1997
Wave Life Sciences develops next-generation nucleic acid drugs that achieve high systemic bioavailability.
$30M
Dec 13, 2015
Equity
Nov 10, 2015
Amwell is a web-based telehealth platform that connects patients with healthcare providers via video, phone and email.
-
Jun 01, 2015
Equity
Sep 17, 2020
Ignyta develops and commercializes targeted molecule therapies for the treatment of cancer.
$42M
Mar 17, 2015
Equity
Mar 13, 2014
Gamida Cell is a Jerusalem-based biotechnology company that develops and commercializes novel therapeutics for the treatment of blood cancer.
$10M
May 14, 2012
Series E
Oct 27, 2018

TEVA News

TEVA Press Releases

Social Media

TEVA Headquarters

5 Basel Street

Petach Tikva, Center District49131

972-926-7267

Driving Directions »

Trending Companies

TEVA Summary

ABOUT

Overview

Teva is a pharmaceutical company that researches and commercializes generic tablets and capsules for respiratory and central nervous system disorders. TEVA was founded in 1901. TEVA's headquarters is located in Petach Tikva, Center District, IL 49131....

CEO

TEVA's President & CEO, Kaare Schultz, currently has an approval rating of 68%. TEVA's primary competitors are Abbott, Merck & Mylan.

Frequently Asked Questions about TEVA

  1. When was TEVA founded?

    TEVA was founded in 1901
  2. Who is TEVA's CEO?

    TEVA's CEO is Kaare Schultz
  3. How much revenue does TEVA generate?

    TEVA generates $16.3B in revenue
  4. How much funding does TEVA have?

    TEVA has historically raised $11.4B in funding
  5. Where is TEVA's headquarters?

    TEVA's headquarters is in Petach Tikva Center District, IL
  1. How many employees does TEVA have?

    TEVA has 42,535 employees
  2. What sector does TEVA operate in?

    TEVA is in Pharmaceuticals
  3. Who are TEVA's competitors?

    TEVA's top competitors are Abbott, Merck, Mylan
  4. Who has TEVA invested in?

    TEVA's has invested in companies such as CTI BioPharma, Wave Life Sciences, Amwell